128 related articles for article (PubMed ID: 34111429)
1. Down-Regulation of a Profibrotic Transforming Growth Factor-β1/Cellular Communication Network Factor 2/Matrix Metalloprotease 9 Axis by Triamcinolone Improves Idiopathic Subglottic Stenosis.
Treviño-Villarreal JH; Reynolds JS; Langston PK; Thompson A; Mitchell JR; Franco RA
Am J Pathol; 2021 Aug; 191(8):1412-1430. PubMed ID: 34111429
[TBL] [Abstract][Full Text] [Related]
2. Awake serial intralesional steroid injections without surgery as a novel targeted treatment for idiopathic subglottic stenosis.
Franco RA; Husain I; Reder L; Paddle P
Laryngoscope; 2018 Mar; 128(3):610-617. PubMed ID: 28988454
[TBL] [Abstract][Full Text] [Related]
3. Voice-Related Quality of Life in Idiopathic Subglottic Stenosis: Effect of Serial Intralesional Steroid Injections.
Naunheim MR; Puka E; Choksawad K; Franco RA
Laryngoscope; 2021 Feb; 131(2):366-369. PubMed ID: 32902886
[TBL] [Abstract][Full Text] [Related]
4. Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis.
Celebi OO; Song SA; Santeerapharp A; Choksawad K; Franco RA
Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):445-450. PubMed ID: 32948895
[TBL] [Abstract][Full Text] [Related]
5. Systemic safety of serial intralesional steroid injection for subglottic stenosis.
Woliansky J; Phyland D; Paddle P
Laryngoscope; 2019 Jul; 129(7):1634-1639. PubMed ID: 30582619
[TBL] [Abstract][Full Text] [Related]
6. Impact of Serial Intralesional Steroid Injections on Idiopathic Subglottic Stenosis.
Hoffman MR; Patro A; Huang LC; Chen SC; Berry LD; Gelbard A; Francis DO;
Laryngoscope; 2023 Sep; 133(9):2255-2263. PubMed ID: 36286239
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Follow-up of 64 Patients With Idiopathic Subglottic Stenosis: Treatment Pathways, Outcomes, and Impact of Serial Intralesional Steroid Injections.
Schoeff S; Hoffman MR; Zhang Y; Yang Q; Dailey SH
Ann Otol Rhinol Laryngol; 2023 Nov; 132(11):1341-1348. PubMed ID: 36840325
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
9. MiR-133 modulates TGF-β1-induced bladder smooth muscle cell hypertrophic and fibrotic response: implication for a role of microRNA in bladder wall remodeling caused by bladder outlet obstruction.
Duan LJ; Qi J; Kong XJ; Huang T; Qian XQ; Xu D; Liang JH; Kang J
Cell Signal; 2015 Feb; 27(2):215-27. PubMed ID: 25451078
[TBL] [Abstract][Full Text] [Related]
10. The effects of qindan-capsule-containing serum on the TGF-β1/ERK signaling pathway, matrix metalloproteinase synthesis and cell function in adventitial fibroblasts.
Yijing L; Liu H; Yuan C; Wang B; Ren M; Yan L; Wang X; Zhang J
Pharm Biol; 2013 Jun; 51(6):712-21. PubMed ID: 23373709
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits TGF-β1-induced connective tissue growth factor expression through the interruption of Smad2 signaling in human gingival fibroblasts.
Chen JT; Wang CY; Chen MH
J Formos Med Assoc; 2018 Dec; 117(12):1115-1123. PubMed ID: 29339038
[TBL] [Abstract][Full Text] [Related]
12. Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-β signaling upregulates CCN2/CTGF expression specifically in muscle fibers.
Valle-Tenney R; Rebolledo DL; Lipson KE; Brandan E
Matrix Biol; 2020 May; 87():48-65. PubMed ID: 31669521
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β1 promotes fibroblast-like synoviocytes migration and invasion via TGF-β1/Smad signaling in rheumatoid arthritis.
Zhu D; Zhao J; Lou A; Huang Q; OuYang Q; Zhu J; Fan M; He Y; Ren H; Yang M
Mol Cell Biochem; 2019 Sep; 459(1-2):141-150. PubMed ID: 31297660
[TBL] [Abstract][Full Text] [Related]
14. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
16. Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals.
Morrison RJ; Katsantonis NG; Motz KM; Hillel AT; Garrett CG; Netterville JL; Wootten CT; Majka SM; Blackwell TS; Drake WP; Gelbard A
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):107-115. PubMed ID: 30322354
[TBL] [Abstract][Full Text] [Related]
17. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
18. Modulated Fibrosis and Mechanosensing of Fibroblasts by SB525334 in Pediatric Subglottic Stenosis.
Ali Akbari Ghavimi S; Aronson MR; Ghaderi DD; Friedman RM; Patel N; Giordano T; Borek RC; Devine CM; Han L; Jacobs IN; Gottardi R
Laryngoscope; 2024 Jan; 134(1):287-296. PubMed ID: 37458368
[TBL] [Abstract][Full Text] [Related]
19. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
20. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
